ATE382636T1 - Fusionsproteine, die zwei lösliche gp130 moleküle enthalten - Google Patents

Fusionsproteine, die zwei lösliche gp130 moleküle enthalten

Info

Publication number
ATE382636T1
ATE382636T1 AT00108691T AT00108691T ATE382636T1 AT E382636 T1 ATE382636 T1 AT E382636T1 AT 00108691 T AT00108691 T AT 00108691T AT 00108691 T AT00108691 T AT 00108691T AT E382636 T1 ATE382636 T1 AT E382636T1
Authority
AT
Austria
Prior art keywords
soluble
sgp130
molecules
fusion proteins
proteins containing
Prior art date
Application number
AT00108691T
Other languages
English (en)
Inventor
Stefan Rose-John
Original Assignee
Conaris Res Inst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Conaris Res Inst Ag filed Critical Conaris Res Inst Ag
Application granted granted Critical
Publication of ATE382636T1 publication Critical patent/ATE382636T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT00108691T 2000-04-21 2000-04-21 Fusionsproteine, die zwei lösliche gp130 moleküle enthalten ATE382636T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00108691A EP1148065B1 (de) 2000-04-21 2000-04-21 Fusionsproteine, die zwei lösliche gp130 Moleküle enthalten

Publications (1)

Publication Number Publication Date
ATE382636T1 true ATE382636T1 (de) 2008-01-15

Family

ID=8168532

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00108691T ATE382636T1 (de) 2000-04-21 2000-04-21 Fusionsproteine, die zwei lösliche gp130 moleküle enthalten

Country Status (8)

Country Link
EP (1) EP1148065B1 (de)
AT (1) ATE382636T1 (de)
CY (1) CY1107380T1 (de)
DE (1) DE60037648T2 (de)
DK (1) DK1148065T3 (de)
ES (1) ES2298106T3 (de)
PT (1) PT1148065E (de)
SI (1) SI1148065T1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100453877B1 (ko) * 2001-07-26 2004-10-20 메덱스젠 주식회사 연쇄체화에 의한 면역 글로블린 융합 단백질의 제조 방법 및 이 방법에 의해 제조된 ＴＮＦＲ/Ｆｃ 융합 단백질, 상기 단백질을 코딩하는 ＤＮＡ, 상기 ＤＮＡ를 포함하는벡터, 및 상기 벡터에 의한 형질전환체
DE10321317A1 (de) * 2003-05-13 2004-12-23 Christian-Albrechts-Universität Zu Kiel Verfahren zum Nachweis des funktionellen IL-6/ sIL-6-Rezeptor-Komplexes und Test-Kit zur Durchführung dieses Verfahrens
EP1491554A1 (de) * 2003-06-23 2004-12-29 CONARIS research institute AG PEGlierte lösliche gp130-Dimeren geignet als Medikament
EP1630232B1 (de) * 2004-08-27 2008-07-02 CONARIS research institute AG Optimierte Nukleotidsequenzen die für sgp130 kodieren
EP1801121A1 (de) * 2005-12-23 2007-06-27 CONARIS research institute AG Lösliche Varianten des Moleküls gp130 nützlich als Arzneimittel
ES2352561T3 (es) 2006-06-30 2011-02-21 Conaris Research Institute Ag Dímeros de sgp 130fc mejorados.
WO2009109584A1 (en) * 2008-03-07 2009-09-11 Ferring International Center S. A. ANTIBODY BINDING ONLY TO IL6-sIL6R COMPLEX
EP2643352B1 (de) * 2010-11-23 2018-05-02 Glaxo Group Limited Antigenbindende proteine zur bindung von oncostatin m (osm)
US20170165334A1 (en) * 2015-12-11 2017-06-15 Tianxin Wang Methods to Treat Diseases with Protein, Peptide, Antigen Modification and Hemopurification
RS65665B1 (sr) 2014-12-01 2024-07-31 Ferring Bv Selektivne kompozicije inhibitora il-6-trans-signalizacije
EP3226888B1 (de) * 2014-12-01 2021-04-21 Ferring B.V. Verabreichung eines selektiven il-6-transsignalisierenden inhibitors
WO2020178193A1 (en) 2019-03-01 2020-09-10 INSERM (Institut National de la Santé et de la Recherche Médicale) Method of treatment of sarcoidosis
JP7781786B2 (ja) 2020-06-10 2025-12-08 フェリング・ベー・フェー アテローム性動脈硬化性心血管疾患を治療するための医薬化合物
WO2022139580A1 (en) 2020-12-22 2022-06-30 Ferring B.V. Blood gene expression biomarkers to predict response in patients with inflammatory bowel diseases
CN114681592A (zh) * 2020-12-31 2022-07-01 天境生物科技(杭州)有限公司 包含可溶性gp130二聚体的制剂和使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262522A (en) * 1991-11-22 1993-11-16 Immunex Corporation Receptor for oncostatin M and leukemia inhibitory factor
US5783672A (en) * 1994-05-26 1998-07-21 Immunex Corporation Receptor for oncostatin M

Also Published As

Publication number Publication date
SI1148065T1 (sl) 2008-06-30
ES2298106T3 (es) 2008-05-16
DK1148065T3 (da) 2008-04-28
DE60037648T2 (de) 2010-06-17
PT1148065E (pt) 2008-04-03
EP1148065A1 (de) 2001-10-24
DE60037648D1 (de) 2008-02-14
CY1107380T1 (el) 2012-12-19
EP1148065B1 (de) 2008-01-02

Similar Documents

Publication Publication Date Title
CY1107380T1 (el) Πρωτεϊνες συντηξης που περιλαμβανουν δυο διαλυτα gp130 μορια
PT745094E (pt) Superagonistas e antagonistas da il-6 humana e metodo para a sua seleccao
EP1191448A4 (de) Informationserfassungssystem
DK0510079T3 (da) Proteiner, der er produceret af humane lymfocytter, DNA-sekvenser, der koder for disse proteiner, og farmaceutiske og biolo
DK0944715T3 (da) Trykmedieret intracellulær administration af molekyler eller mikropartikler
FI880267A7 (fi) Instrumentti keinosiemennystä, alkionsiirtoa tai munarakkulan nesteiden näytteenottoa varten nisäkkäissä.
ES2093623T3 (es) Receptores monovalentes y oligovalentes, bioespecificos y oligoespecificos, su preparacion y empleo.
EP0670730A4 (de) Fusionsprotein, das dem rezeptor des tumornekrose-faktors enthält.
EA200300362A1 (ru) Способ генерирования молекулярно-функциональной сети
EP0804483A4 (de) Aus den vorstufen des mage tumor-abstossungsantigen abstammende einzelne peptede, die hla-a2 moleküle komplexieren
ATE466930T1 (de) Universelles sammelmedium
TR199701544T1 (xx) Yeni dolastatin t�revleri,bunlar�n haz�rlanmas� ve kullan�lmas�.
WO2004061620A3 (en) Temporal affinity analysis using reuse signatures
ATE187565T1 (de) Emulator für eine sql relationelle datenbank
DE69132346D1 (de) 4-Chlor-1-(ethoxymethyl)-2-(p-chlorophenyl)-5-(trifluoromethyl)pyrrol-3-carbonitril und dessen Verwendung als Insektizid, Nematozid und Acarizid
DK0414019T3 (da) Substituerede N-(quinolin-2-yl-methoxy)benzyl-sulfonylurinstoffer
FI20010724A0 (fi) Menetelmä ja laitteisto hajautetun tietokannan ja sitä hyödyntävän sovelluksen käyttämiseksi päätelaiteriippumattomasti
NZ313199A (en) Marine navigation device using two pivoting discs and rules to determine position on chart from GPS data
BR9611947A (pt) Isoindolonas fundidas como inibidores da quinase da proteina c
ATE305612T1 (de) Reporterverbindungen und verfahren zur auffindung von hochspezifische proteaseaktivität
DE3888887D1 (de) Monoklonale Antikörper gegen E7-Protein des Humanen Papillomvirus Typ 16, Verfahren zu ihrer Herstellung sowie ihre Verwendung.
WO1992011367A3 (en) Lipid receptors for microorganisms and corresponding adhesins, dna sequences encoding adhesins, and use thereof
EP1291846A3 (de) Vibrato erzeugende Vorrichtung zur Stimmsynthese
IS2219B (is) Aðferð til nafnlausrar skráningar, geymslu og notkunar á líkamsefni og/eða upplýsingum fengnum þar úr.
Schreiner et al. Investigation of driving behavior changes associated with manual and voice-activated phone-dialing in a real-world environment

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1148065

Country of ref document: EP